- Home
- TXG vs IMAX Comparison
TXG vs IMAX Comparison
Compare TXG & IMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TXG | IMAX |
|---|---|---|
| Founded | 2012 | 1967 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | 2019 | 1997 |
Fundamental Metrics
Financial Performance| Metric | TXG | IMAX |
|---|---|---|
| Price | $21.69 | $35.02 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 10 |
| Target Price | $20.25 | ★ $44.50 |
| AVG Volume (30 Days) | ★ 2.4M | 1.1M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 76.97 | 31.25 |
| EPS | N/A | ★ 0.07 |
| Revenue | $245,893,000.00 | ★ $410,212,000.00 |
| Revenue This Year | N/A | $9.79 |
| Revenue Next Year | $7.33 | $7.51 |
| P/E Ratio | ★ N/A | $518.57 |
| Revenue Growth | ★ 68.06 | 16.47 |
| 52 Week Low | $7.72 | $23.91 |
| 52 Week High | $26.45 | $43.16 |
Technical Indicators
Market Signals| Indicator | TXG | IMAX |
|---|---|---|
| Relative Strength Index (RSI) | 47.90 | 39.14 |
| Support Level | $11.66 | $33.64 |
| Resistance Level | $23.43 | $37.52 |
| Average True Range (ATR) | 1.42 | 1.51 |
| MACD | -0.32 | -0.02 |
| Stochastic Oscillator | 31.02 | 25.15 |
Price Performance
Historical ComparisonAbout TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
About IMAX Imax Corporation
Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.